BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 25935002)

  • 1. Second-generation compound for the modulation of utrophin in the therapy of DMD.
    Guiraud S; Squire SE; Edwards B; Chen H; Burns DT; Shah N; Babbs A; Davies SG; Wynne GM; Russell AJ; Elsey D; Wilson FX; Tinsley JM; Davies KE
    Hum Mol Genet; 2015 Aug; 24(15):4212-24. PubMed ID: 25935002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Embryonic myosin is a regeneration marker to monitor utrophin-based therapies for DMD.
    Guiraud S; Edwards B; Squire SE; Moir L; Berg A; Babbs A; Ramadan N; Wood MJ; Davies KE
    Hum Mol Genet; 2019 Jan; 28(2):307-319. PubMed ID: 30304405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of dystrophin and utrophin gene transfer in immunocompetent muscular dystrophy (mdx) mice.
    Ebihara S; Guibinga GH; Gilbert R; Nalbantoglu J; Massie B; Karpati G; Petrof BJ
    Physiol Genomics; 2000 Sep; 3(3):133-44. PubMed ID: 11015608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xanthine oxidase is hyper-active in Duchenne muscular dystrophy.
    Lindsay A; McCourt PM; Karachunski P; Lowe DA; Ervasti JM
    Free Radic Biol Med; 2018 Dec; 129():364-371. PubMed ID: 30312761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological activation of PPARbeta/delta stimulates utrophin A expression in skeletal muscle fibers and restores sarcolemmal integrity in mature mdx mice.
    Miura P; Chakkalakal JV; Boudreault L; Bélanger G; Hébert RL; Renaud JM; Jasmin BJ
    Hum Mol Genet; 2009 Dec; 18(23):4640-9. PubMed ID: 19744959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of Utrophin Levels with the Dystrophin Protein Complex and Muscle Fibre Regeneration in Duchenne and Becker Muscular Dystrophy Muscle Biopsies.
    Janghra N; Morgan JE; Sewry CA; Wilson FX; Davies KE; Muntoni F; Tinsley J
    PLoS One; 2016; 11(3):e0150818. PubMed ID: 26974331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-immunogenic utrophin gene therapy for the treatment of muscular dystrophy animal models.
    Song Y; Morales L; Malik AS; Mead AF; Greer CD; Mitchell MA; Petrov MT; Su LT; Choi ME; Rosenblum ST; Lu X; VanBelzen DJ; Krishnankutty RK; Balzer FJ; Loro E; French R; Propert KJ; Zhou S; Kozyak BW; Nghiem PP; Khurana TS; Kornegay JN; Stedman HH
    Nat Med; 2019 Oct; 25(10):1505-1511. PubMed ID: 31591596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Daily treatment with SMTC1100, a novel small molecule utrophin upregulator, dramatically reduces the dystrophic symptoms in the mdx mouse.
    Tinsley JM; Fairclough RJ; Storer R; Wilkes FJ; Potter AC; Squire SE; Powell DS; Cozzoli A; Capogrosso RF; Lambert A; Wilson FX; Wren SP; De Luca A; Davies KE
    PLoS One; 2011 May; 6(5):e19189. PubMed ID: 21573153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of FHL1 as a therapeutic target for Duchenne muscular dystrophy.
    D'Arcy CE; Feeney SJ; McLean CA; Gehrig SM; Lynch GS; Smith JE; Cowling BS; Mitchell CA; McGrath MJ
    Hum Mol Genet; 2014 Feb; 23(3):618-36. PubMed ID: 24087791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein-Anchoring Therapy of Biglycan for Mdx Mouse Model of Duchenne Muscular Dystrophy.
    Ito M; Ehara Y; Li J; Inada K; Ohno K
    Hum Gene Ther; 2017 May; 28(5):428-436. PubMed ID: 27485975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic remodeling of dystrophic skeletal muscle reveals biological roles for dystrophin and utrophin in adaptation and plasticity.
    Hardee JP; Martins KJB; Miotto PM; Ryall JG; Gehrig SM; Reljic B; Naim T; Chung JD; Trieu J; Swiderski K; Philp AM; Philp A; Watt MJ; Stroud DA; Koopman R; Steinberg GR; Lynch GS
    Mol Metab; 2021 Mar; 45():101157. PubMed ID: 33359740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying FDA-Approved Drugs that Upregulate Utrophin A as a Therapeutic Strategy for Duchenne Muscular Dystrophy.
    Péladeau C; Jasmin BJ
    Methods Mol Biol; 2023; 2587():495-510. PubMed ID: 36401046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microutrophin expression in dystrophic mice displays myofiber type differences in therapeutic effects.
    Banks GB; Chamberlain JS; Odom GL
    PLoS Genet; 2020 Nov; 16(11):e1009179. PubMed ID: 33175853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utrophin influences mitochondrial pathology and oxidative stress in dystrophic muscle.
    Kennedy TL; Moir L; Hemming S; Edwards B; Squire S; Davies K; Guiraud S
    Skelet Muscle; 2017 Oct; 7(1):22. PubMed ID: 29065908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of sarcospan exacerbates pathology in mdx mice, but does not affect utrophin amelioration of disease.
    Gibbs EM; McCourt JL; Shin KM; Hammond KG; Marshall JL; Crosbie RH
    Hum Mol Genet; 2021 Apr; 30(3-4):149-159. PubMed ID: 33432327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy.
    Siemionow M; Langa P; Brodowska S; Kozlowska K; Zalants K; Budzynska K; Heydemann A
    Stem Cell Rev Rep; 2022 Dec; 18(8):2872-2892. PubMed ID: 35590083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscle structure influences utrophin expression in mdx mice.
    Banks GB; Combs AC; Odom GL; Bloch RJ; Chamberlain JS
    PLoS Genet; 2014 Jun; 10(6):e1004431. PubMed ID: 24922526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stabilization of the cardiac sarcolemma by sarcospan rescues DMD-associated cardiomyopathy.
    Parvatiyar MS; Brownstein AJ; Kanashiro-Takeuchi RM; Collado JR; Dieseldorff Jones KM; Gopal J; Hammond KG; Marshall JL; Ferrel A; Beedle AM; Chamberlain JS; Renato Pinto J; Crosbie RH
    JCI Insight; 2019 Apr; 5(11):. PubMed ID: 31039133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of full-length utrophin prevents muscular dystrophy in mdx mice.
    Tinsley J; Deconinck N; Fisher R; Kahn D; Phelps S; Gillis JM; Davies K
    Nat Med; 1998 Dec; 4(12):1441-4. PubMed ID: 9846586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.